Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Patients with Moderate-to-Severe Atopic Dermatitis Mainta... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment
0
Authors
Jonathan Silverberg
13 more
Jonathan Silverberg
•
Andreas Wollenberg
11 more
•
Sonja Ständer
Published
August 1, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Dermatology and Therapy
Topics
Medicine
Dermatology
Rheumatology
Immunology And Allergy
Atopic Dermatitis
DOI
10.1007/s13555-024-01226-9
License
CC-BY-NC
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Dermatology and Therapy
Topics
Medicine
Dermatology
Rheumatology
Immunology And Allergy
Atopic Dermatitis
DOI
10.1007/s13555-024-01226-9
License
CC-BY-NC
